COVID-19 neutrophils expressed decreased levels of the activation marker CD11b and a lack of CD62L shedding, which has previously been observed in sepsis [58], alongside reduced levels of PD-L1 involved in immunosuppression. This evidence concerns the gene SELL and COVID-19.